MNPR Earnings

Quarterly EPS
$-0.37
Q3 2024
$-2.21
Q4 2024
$-0.38
Q1 2025
$-0.35
Q2 2025
$-0.48
Q3 2025
$-0.61
Q4 2025
$-0.46
Q1 2026
$-0.62
Q2 2026
Latest RevenueN/A
Latest Net Income-5313300
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.620-5313300-77.1%
Q1 2026-$0.460-3893050-21.1%
Q4 2025-$0.610-5200794+72.4%
Q3 2025-$0.480-3437602-29.7%
Q2 2025-$0.350-2453526+28.6%
Q1 2025-$0.380-2624972+25.5%
Q4 2024-$2.210-10925608-531.4%
Q3 2024-$0.370-1304276+46.4%
Q2 2024-$0.490-1715309
Q1 2024-$0.510-1641226
Q4 2023-$0.350-1813915
Q3 2023-$0.690-1953734
Monopar Therapeutics (MNPR) — Earnings